Twist Bioscience: Pay

Twist Bioscience paid its 5 named executives $33.0M in total in FY2025 (Sep). CEO Emily Leproust was paid $13.8M of that.

Pay$100 in the stock at the end of FY20 → $37
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Emily LeproustPh.D. Chief Executive Officer and Chair of the Board
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
FY2022 (Sep)Not disclosed
FY2021 (Sep)Not disclosed
5 years
Patrick Finn, Ph.D.President and Chief Operating Officer
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
FY2022 (Sep)Not disclosed
FY2021 (Sep)Not disclosed
5 years
Adam LaponisChief Financial Officer
FY2025 (Sep)
FY2024 (Sep)
2 years
Dennis ChoChief Legal Officer and Corporate Secretary
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)Not disclosed
FY2022 (Sep)Not disclosed
4 years
Paula GreenSenior Vice President of Human Resources
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
3 years

CEO pay against the pay peers

In FY2025 (Sep), the median CEO pay of the 6 peers with pay on file was $9.4M. The CEO of Twist Bioscience was paid $13.8M, 46% above the median.

  1. 1Natera
  2. 2INSMED
  3. 3Twist Bioscience
  4. 4Ultragenyx Pharmaceutical
  5. 5Veracyte
  6. 610x Genomics
  7. 7Schrodinger
  8. 8Azenta, Inc.Not disclosed
  9. 9BioLife Solutions, Inc.Not disclosed
  10. 10CareDX, Inc.Not disclosed
  11. 11Cytek Biosciences, Inc.Not disclosed
  12. 12Guardant HealthNot disclosed
  13. 13Maravai LifeSciences Holdings, Inc.Not disclosed
  14. 14NeoGenomics, Inc.Not disclosed
  15. 15NovoCure LimitedNot disclosed
  16. 16Pacific Biosciences of California, Inc.Not disclosed
  17. 17Quanterix CorporationNot disclosed
  18. 18REGENXBIO Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.